eF-site ID 1bll-E
PDB Code 1bll
Chain E

click to enlarge
Title X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH AMASTATIN: FORMULATION OF A CATALYTIC MECHANISM FEATURING A GEM-DIOLATE TRANSITION STATE
Classification HYDROLASE/HYDROLASE INHIBITOR
Compound LEUCINE AMINOPEPTIDASE
Source null (1BLL)
Sequence E:  TKGLVLGIYSKEDEPQFTSAGENFNKLVSGKLREILNISG
PPLKAGKTRTFYGLHEDFPSVVVVGLGKKTAGIDEQENWH
EGKENIRAAVAAGCRQIQDLEIPSVEVDPCGDAQAAAEGA
VLGLYEYDDLKQKRKVVVSAKLHGSEDQEAWQRGVLFASG
QNLARRLMETPANEMTPTKFAEIVEENLKSASIKTDVFIR
PKSWIEEQEMGSFLSVAKGSEEPPVFLEIHYKGSPNASEP
PLVFVGKGITFDSGGISIKAAANMDLMRADMGGAATICSA
IVSAAKLDLPINIVGLAPLCENMPSGKANKPGDVVRARNG
KTIQVDNTDAEGRLILADALCYAHTFNPKVIINAATLTGA
MDIALGSGATGVFTNSSWLWNKLFEASIETGDRVWRMPLF
EHYTRQVIDCQLADVNNIGKYRSAGACTAAAFLKEFVTHP
KWAHLDIAGVMTNKDEVPYLRKGMAGRPTRTLIEFLFRFS
Q
Description


Functional site

1) chain E
residue 255
type
sequence D
description BINDING SITE FOR RESIDUE ZN E 488
source : AC1

2) chain E
residue 332
type
sequence D
description BINDING SITE FOR RESIDUE ZN E 488
source : AC1

3) chain E
residue 334
type
sequence E
description BINDING SITE FOR RESIDUE ZN E 488
source : AC1

4) chain E
residue 250
type
sequence K
description BINDING SITE FOR RESIDUE ZN E 489
source : AC2

5) chain E
residue 255
type
sequence D
description BINDING SITE FOR RESIDUE ZN E 489
source : AC2

6) chain E
residue 273
type
sequence D
description BINDING SITE FOR RESIDUE ZN E 489
source : AC2

7) chain E
residue 334
type
sequence E
description BINDING SITE FOR RESIDUE ZN E 489
source : AC2

8) chain E
residue 250
type
sequence K
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

9) chain E
residue 255
type
sequence D
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

10) chain E
residue 262
type
sequence K
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

11) chain E
residue 270
type
sequence M
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

12) chain E
residue 273
type
sequence D
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

13) chain E
residue 332
type
sequence D
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

14) chain E
residue 334
type
sequence E
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

15) chain E
residue 336
type
sequence R
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

16) chain E
residue 359
type
sequence T
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

17) chain E
residue 360
type
sequence L
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

18) chain E
residue 362
type
sequence G
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

19) chain E
residue 363
type
sequence A
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

20) chain E
residue 366
type
sequence I
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

21) chain E
residue 366
type
sequence I
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

22) chain E
residue 425
type
sequence R
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

23) chain E
residue 428
type
sequence G
description BINDING SITE FOR CHAIN I OF AMASTATIN
source : AC3

24) chain E
residue 294
type catalytic
sequence I
description 587
source MCSA : MCSA1

25) chain E
residue 368
type catalytic
sequence L
description 587
source MCSA : MCSA1

26) chain E
residue 45
type MOD_RES
sequence P
description N6-succinyllysine => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI9

27) chain E
residue 61
type MOD_RES
sequence F
description N6-succinyllysine => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI9

28) chain E
residue 103
type MOD_RES
sequence L
description N6-succinyllysine => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI9

29) chain E
residue 476
type MOD_RES
sequence I
description N6-succinyllysine => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI9

30) chain E
residue 180
type MOD_RES
sequence P
description Phosphoserine => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI10

31) chain E
residue 194
type MOD_RES
sequence A
description Phosphoserine => ECO:0000250|UniProtKB:P28838
source Swiss-Prot : SWS_FT_FI11

32) chain E
residue 238
type MOD_RES
sequence P
description Phosphoserine => ECO:0000250|UniProtKB:P28838
source Swiss-Prot : SWS_FT_FI11

33) chain E
residue 455
type MOD_RES
sequence T
description N6-succinyllysine; alternate => ECO:0000250|UniProtKB:Q9CPY7
source Swiss-Prot : SWS_FT_FI12

34) chain E
residue 294
type ACT_SITE
sequence I
description ACT_SITE => ECO:0000269|PubMed:7578088
source Swiss-Prot : SWS_FT_FI1

35) chain E
residue 368
type ACT_SITE
sequence L
description ACT_SITE => ECO:0000269|PubMed:7578088
source Swiss-Prot : SWS_FT_FI1

36) chain E
residue 202
type BINDING
sequence I
description BINDING => ECO:0000305|PubMed:7619821, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI2

37) chain E
residue 203
type BINDING
sequence R
description BINDING => ECO:0000305|PubMed:7619821, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI2

38) chain E
residue 205
type BINDING
sequence K
description BINDING => ECO:0000305|PubMed:7619821, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI2

39) chain E
residue 303
type BINDING
sequence C
description BINDING => ECO:0000305|PubMed:7619821, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI2

40) chain E
residue 282
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:16519517, ECO:0000269|PubMed:17157838, ECO:0007744|PDB:2EWB, ECO:0007744|PDB:2J9A
source Swiss-Prot : SWS_FT_FI3

41) chain E
residue 287
type BINDING
sequence A
description BINDING => ECO:0000269|PubMed:16519517, ECO:0000269|PubMed:17157838, ECO:0007744|PDB:2EWB, ECO:0007744|PDB:2J9A
source Swiss-Prot : SWS_FT_FI3

42) chain E
residue 305
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:16519517, ECO:0000269|PubMed:17157838, ECO:0007744|PDB:2EWB, ECO:0007744|PDB:2J9A
source Swiss-Prot : SWS_FT_FI3

43) chain E
residue 292
type BINDING
sequence L
description BINDING => ECO:0000269|PubMed:7619821, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI4

44) chain E
residue 294
type BINDING
sequence I
description BINDING => ECO:0000269|PubMed:7578088, ECO:0000269|PubMed:7619821, ECO:0007744|PDB:1LAN, ECO:0007744|PDB:1LCP
source Swiss-Prot : SWS_FT_FI5

45) chain E
residue 364
type BINDING
sequence M
description BINDING => ECO:0000269|PubMed:16519517, ECO:0000269|PubMed:17157838, ECO:0000269|PubMed:8506345, ECO:0007744|PDB:2EWB, ECO:0007744|PDB:2J9A
source Swiss-Prot : SWS_FT_FI6

46) chain E
residue 42
type MOD_RES
sequence S
description Phosphoserine => ECO:0000250|UniProtKB:Q68FS4
source Swiss-Prot : SWS_FT_FI8

47) chain E
residue 54
type MOD_RES
sequence F
description Phosphoserine => ECO:0000250|UniProtKB:Q68FS4
source Swiss-Prot : SWS_FT_FI8

48) chain E
residue 330-337
type prosite
sequence NTDAEGRL
description CYTOSOL_AP Cytosol aminopeptidase signature. NTDAEGRL
source prosite : PS00631

49) chain E
residue 366
type BINDING
sequence I
description BINDING => ECO:0000269|PubMed:16519517, ECO:0000269|PubMed:17157838, ECO:0000269|PubMed:8506345, ECO:0007744|PDB:1BPM, ECO:0007744|PDB:2EWB, ECO:0007744|PDB:2J9A
source Swiss-Prot : SWS_FT_FI7


Display surface

Download
Links